CN109198354A - Intelligence development cerebrum tonifying DHA solid beverage and preparation method thereof - Google Patents
Intelligence development cerebrum tonifying DHA solid beverage and preparation method thereof Download PDFInfo
- Publication number
- CN109198354A CN109198354A CN201811131554.XA CN201811131554A CN109198354A CN 109198354 A CN109198354 A CN 109198354A CN 201811131554 A CN201811131554 A CN 201811131554A CN 109198354 A CN109198354 A CN 109198354A
- Authority
- CN
- China
- Prior art keywords
- dha
- powder
- solid beverage
- intelligence development
- algal oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 24
- 239000007787 solid Substances 0.000 title claims abstract description 22
- 210000004720 cerebrum Anatomy 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 45
- 241000229143 Hippophae Species 0.000 claims abstract description 19
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 17
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 17
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 14
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 14
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 13
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 13
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 13
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 13
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 13
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 13
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000004321 preservation Methods 0.000 claims description 9
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims description 8
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 6
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 claims description 5
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 5
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 claims description 5
- 235000016831 stigmasterol Nutrition 0.000 claims description 5
- 229940032091 stigmasterol Drugs 0.000 claims description 5
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 claims description 5
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims description 4
- 238000010792 warming Methods 0.000 claims description 4
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 claims description 3
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000003651 drinking water Substances 0.000 claims description 3
- 235000020188 drinking water Nutrition 0.000 claims description 3
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000010008 shearing Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 claims description 2
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 claims description 2
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 claims description 2
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 claims description 2
- 235000000431 campesterol Nutrition 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- GHIZCSMTYWOBQA-BZSCQJQFSA-N spinasterol Natural products CC[C@H](C=C[C@@H](C)[C@@H]1CC[C@@]2(C)C3=CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C GHIZCSMTYWOBQA-BZSCQJQFSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 claims 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 claims 1
- 206010056474 Erythrosis Diseases 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 239000000470 constituent Substances 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 34
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 33
- 239000000203 mixture Substances 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N Behenic acid Natural products CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- KFEVDPWXEVUUMW-UHFFFAOYSA-N docosanoic acid Natural products CCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 KFEVDPWXEVUUMW-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The present invention relates to technical field of functional drink, it is more particularly to a kind of intelligence development cerebrum tonifying DHA solid beverage and preparation method thereof；The intelligence development cerebrum tonifying DHA solid beverage includes the raw material of following weight fraction: DHA algal oil powder 1~20%, seabuckthorn fruit powder 1~50%, ginkgo biloba p.e 1~10%, phytosterol 1~20%, antierythrite 10~30%, microcrystalline cellulose 1~5%, maltodextrin 10~50%；The beneficial effects of the present invention are: DHA algal oil powder and seabuckthorn fruit powder, ginkgo biloba p.e and phytosterol reasonable compatibility, these ingredients cooperate, and synergistic effect can slow down the oxidation of DHA, extend the shelf life of beverage.In addition, seabuckthorn fruit powder can cover the fishy smell of DHA algal oil powder, assigns product strong sour-sweet taste, promote product quality and mouthfeel.Method provided by the invention is simple, can largely retain the active constituent in material, improves product quality.
Description
Technical field
The present invention relates to technical field of functional drink, it is more particularly to a kind of intelligence development cerebrum tonifying DHA solid beverage and its preparation
Method.
Background technique
As modern society's competitiveness increasingly increases, rhythm of life is accelerated, and the crowd in inferior health is more and more, mainly
Show that mental loss is big, memory loss, hypoimmunity carrys out very big puzzlement to daily life and work belt.Cis- 4,
7,10,13,16,19- docosanoic acid (Docosahexaenoic Acid, DHA), are commonly called as docosapentaenoic acid, belong to ω -3
Important member in unsaturated fat family is to maintain fatty acid composition important in nervous system cell and cellula visualis, right
The normal performance of human body physiological function and the prevention and treatment important role of a variety of diseases.It is related that DHA is added in solid beverage
DHA it is a kind of utilize form, have it is quick and easy, easily stored, the advantages such as nutrition needed for body metabolism can be replenished in time.
There are the following problems when currently, DHA being applied in solid beverage: 1, the fishy smell of DHA algal oil powder is heavier, and mouthfeel is bad；2,DHA
For polyunsaturated fatty acid, it is easy oxidation Kazakhstan under the conditions ofs oxygen, light, heat etc. and loses, shelf life is short.
Summary of the invention
According to the above-mentioned deficiencies of the prior art, the technical problem to be solved by the present invention is to propose a kind of intelligence development cerebrum tonifying DHA
Solid beverage and preparation method thereof can slow down the oxidation of DHA, extend shelf life, change by improving formula and production technology
The mouthfeel of kind product.
In order to solve the above-mentioned technical problem, the technical solution adopted by the present invention are as follows: a kind of intelligence development cerebrum tonifying DHA solid beverage,
Raw material including following weight fraction: DHA algal oil powder 1~20%, seabuckthorn fruit powder 1~50%, ginkgo biloba p.e 1~10% are planted
Object sterol 1~20%, antierythrite 10~30%, microcrystalline cellulose 1~5%, maltodextrin 10~50%.
Preferably, the intelligence development cerebrum tonifying DHA solid beverage, the raw material including following weight fraction: DHA algal oil powder 5~
15%, seabuckthorn fruit powder 10~40%, ginkgo biloba p.e 2~8%, phytosterol 5~15%, antierythrite 15~25%, crystallite
Cellulose 1~5%, maltodextrin 15~45%.
Preferably, the intelligence development cerebrum tonifying DHA solid beverage, the raw material including following weight fraction: DHA algal oil powder 7%,
Seabuckthorn fruit powder 22%, ginkgo biloba p.e 6%, phytosterol 12%, antierythrite 20%, microcrystalline cellulose 2%, maltodextrin
31%.
Preferably, in the DHA algal oil powder DHA content >=3%.
Preferably, the phytosterol is in cupreol, campesterol, stigmasterol, spinasterol, ergosterol
Any one.
The present invention also provides a kind of preparation methods of intelligence development cerebrum tonifying DHA solid beverage as described above, include the following steps:
(1) after antierythrite, microcrystalline cellulose, maltodextrin sieve with 100 mesh sieve respectively, the drinking water of 5~10 times of amounts is put into
In, 70~95 DEG C are warming up to, phytosterol is added later, shearing mixes under constant temperature conditions；
(2) gained mixed material is cooled to 35~45 DEG C, DHA algal oil powder, the sea-buckthorn for sieving with 100 mesh sieve processing in advance is added
Powder and ginkgo biloba p.e, homogenization 30~60 minutes；
(3) gained homogeneous product is cooled to -20~-15 DEG C with the cooling rate of 60~90 DEG C/h, heat preservation stands 1~3
Hour, adjusting environment vacuum degree is 5~15Pa, and then the heating rate of 20~40 DEG C/h makes material be warming up to 0~10 DEG C, heat preservation
1~3 hour is stood, finally rises to 25~35 DEG C with the heating rate of 20~40 DEG C/h, heat preservation stands 1~3 hour；
(4) gained powder is crossed into 100~300 meshes, packed, packaging.
The beneficial effects of the present invention are: vitamin C is rich in seabuckthorn fruit powder, there is phytosterol good antioxygen to be turned into
With ginkgo biloba p.e also has powerful anti-oxidant and Scavenging ability, while helping to promote cerebral blood flow, changes
The problems such as kind memory and attention.DHA algal oil powder and seabuckthorn fruit powder, ginkgo biloba p.e and phytosterol reasonable compatibility, these
Ingredient cooperates, and synergistic effect can slow down the oxidation of DHA, extend the shelf life of beverage.In addition, seabuckthorn fruit powder can cover DHA
The fishy smell of algae oil powder assigns product strong sour-sweet taste, promotes product quality and mouthfeel.Method provided by the invention is simple,
The active constituent in material can largely be retained, improve product quality.
Specific embodiment
Below by the description to embodiment, the shape of for example related each component of a specific embodiment of the invention, structure
It makes, the mutual alignment between each section and connection relationship, the effect of each section and working principle, manufacturing process and the side of operating with
Method etc., is described in further detail, completeer to help those skilled in the art to have inventive concept of the invention, technical solution
Whole, accurate and deep understanding.
In following embodiment, Xiang biology Co., Ltd, DHA content 10% DHA algal oil powder: are pleased purchased from Shandong；Seabuckthorn fruit powder:
Purchased from Shaanxi Zhong Xin Bioisystech Co., Ltd；Ginkgo biloba p.e: it is purchased from Shaanxi Yang County Zhi Jian medicine company Science and Technology Ltd.；It plants
Object sterol: it is purchased from Xi'an Wei Ao Biotechnology Co., Ltd；Antierythrite: it is purchased from Nanjing Song Guan Biotechnology Co., Ltd；It is micro-
Crystalline cellulose: it is purchased from Xi'an La Weiya Biotechnology Co., Ltd；Maltodextrin: it is purchased from Shandong Jia Yu Chemical Co., Ltd..
Embodiment 1:
The present embodiment provides a kind of intelligence development cerebrum tonifying DHA solid beverage, the raw materials including following weight fraction: DHA algal oil powder
7%, seabuckthorn fruit powder 22%, ginkgo biloba p.e 6%, cupreol 12%, antierythrite 20%, microcrystalline cellulose 2%, malt paste
Essence 31%.
The preparation method of above-mentioned intelligence development cerebrum tonifying DHA solid beverage, includes the following steps:
(1) it after antierythrite, microcrystalline cellulose, maltodextrin sieve with 100 mesh sieve respectively, puts into the drinking water of 8 times of amounts, rises
Phytosterol is added to 85 DEG C in temperature later, and shearing mixes under constant temperature conditions；
(2) gained mixed material is cooled to 40 DEG C, be added the DHA algal oil powder for sieving with 100 mesh sieve processing in advance, seabuckthorn fruit powder and
Ginkgo biloba p.e, homogenization 45 minutes；
(3) gained homogeneous product being cooled to -20~-15 DEG C with the cooling rate of 80 DEG C/h, heat preservation stands 1.5 hours,
Adjusting environment vacuum degree is 10Pa, then so that material is warming up to 5 DEG C with the heating rate of 30 DEG C/h, heat preservation stands 2 hours, finally
30 DEG C are risen to the heating rate of 30 DEG C/h, heat preservation stands 2 hours；
(4) water content of gained powder is detected, gained powder is crossed into 100~300 meshes, packed, packaging.
Embodiment 2:
Using the preparation method of embodiment 1, the difference is that: phytosterol is stigmasterol, and composition of raw materials is as follows: DHA
Algae oil powder 12%, seabuckthorn fruit powder 26%, ginkgo biloba p.e 4%, stigmasterol 6%, antierythrite 15%, microcrystalline cellulose 3%, wheat
Bud dextrin 34%.
Embodiment 3:
Using the preparation method of embodiment 1, the difference is that: phytosterol is ergosterol, and composition of raw materials is as follows:
DHA algal oil powder 16%, seabuckthorn fruit powder 35%, ginkgo biloba p.e 5%, stigmasterol 4%, antierythrite 12%, microcrystalline cellulose
2%, maltodextrin 26%.
Comparative example 1:
Using the preparation method of embodiment 1, the difference is that: composition of raw materials are as follows: DHA algal oil powder 7%, ginkgo leaf extract
Object 6%, cupreol 12%, antierythrite 20%, microcrystalline cellulose 2%, maltodextrin 53%.
Solid beverage made from solid beverage made from 10g embodiment 1 and comparative example 1 is taken respectively, is sent with warm water
With the test of period of storage variation etc., as a result as shown in table 1 below clothes carry out mouthfeel:
The present invention is exemplarily described above, it is clear that present invention specific implementation is not subject to the restrictions described above,
As long as using the improvement for the various unsubstantialities that the inventive concept and technical scheme of the present invention carry out, or not improved this is sent out
Bright conception and technical scheme directly apply to other occasions, within the scope of the present invention.Protection of the invention
Range should be determined by the scope of protection defined in the claims.
Claims (6)
1. a kind of intelligence development cerebrum tonifying DHA solid beverage, it is characterised in that: the raw material including following weight fraction: DHA algal oil powder 1~
20%, seabuckthorn fruit powder 1~50%, ginkgo biloba p.e 1~10%, phytosterol 1~20%, antierythrite 10~30%, crystallite
Cellulose 1~5%, maltodextrin 10~50%.
2. intelligence development cerebrum tonifying DHA solid beverage according to claim 1, it is characterised in that: the original including following weight fraction
Material: DHA algal oil powder 5~15%, seabuckthorn fruit powder 10~40%, ginkgo biloba p.e 2~8%, phytosterol 5~15%, erythrose
Alcohol 15~25%, microcrystalline cellulose 1~5%, maltodextrin 15~45%.
3. intelligence development cerebrum tonifying DHA solid beverage according to claim 1, it is characterised in that: the original including following weight fraction
Material: DHA algal oil powder 7%, seabuckthorn fruit powder 22%, ginkgo biloba p.e 6%, phytosterol 12%, antierythrite 20%, microcrystalline cellulose
Element 2%, maltodextrin 31%.
4. intelligence development cerebrum tonifying DHA solid beverage according to any one of claim 1-3, which is characterized in that the DHA algal oil
Content >=3% of DHA in powder.
5. intelligence development cerebrum tonifying DHA solid beverage according to any one of claim 1-3, which is characterized in that the plant steroid
Any one of alcohol in cupreol, campesterol, stigmasterol, spinasterol, ergosterol.
6. a kind of preparation method of intelligence development cerebrum tonifying DHA solid beverage according to any one of claim 1-3, feature exist
In including the following steps:
(1) it after antierythrite, microcrystalline cellulose, maltodextrin sieve with 100 mesh sieve respectively, puts into the drinking water of 5~10 times of amounts, rises
Phytosterol is added to 70~95 DEG C in temperature later, and shearing mixes under constant temperature conditions；
(2) gained mixed material is cooled to 35~45 DEG C, be added the DHA algal oil powder for sieving with 100 mesh sieve processing in advance, seabuckthorn fruit powder and
Ginkgo biloba p.e, homogenization 30~60 minutes；
(3) gained homogeneous product being cooled to -20~-15 DEG C with the cooling rate of 60~90 DEG C/h, heat preservation stands 1~3 hour,
Adjusting environment vacuum degree is 5~15Pa, and then the heating rate of 20~40 DEG C/h makes material be warming up to 0~10 DEG C, and heat preservation stands 1
~3 hours, 25~35 DEG C finally are risen to the heating rate of 20~40 DEG C/h, heat preservation stands 1~3 hour；
(4) gained powder is crossed into 100~300 meshes, packed, packaging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811131554.XA CN109198354A (en) | 2018-09-27 | 2018-09-27 | Intelligence development cerebrum tonifying DHA solid beverage and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811131554.XA CN109198354A (en) | 2018-09-27 | 2018-09-27 | Intelligence development cerebrum tonifying DHA solid beverage and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109198354A true CN109198354A (en) | 2019-01-15 |
Family
ID=64981683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811131554.XA Withdrawn CN109198354A (en) | 2018-09-27 | 2018-09-27 | Intelligence development cerebrum tonifying DHA solid beverage and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109198354A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1293963A (en) * | 2000-10-31 | 2001-05-09 | 华南理工大学 | Health-care microalga food and its preparing process |
| CN104687178A (en) * | 2015-03-13 | 2015-06-10 | 上海益力健营养品有限公司 | Solid beverage capable of being directly taken orally and preparation method thereof |
| CN105725005A (en) * | 2016-02-03 | 2016-07-06 | 山东禹王制药有限公司 | Protein type solid beverage with DHA fishy smell improved and preparing method thereof |
| CN106616184A (en) * | 2016-12-27 | 2017-05-10 | 哈药集团技术中心 | Mulberry DHA solid beverage, and preparation method thereof |
| CN108541859A (en) * | 2018-02-12 | 2018-09-18 | 广州富诺健康科技股份有限公司 | A kind of DHA algal oil solid beverage |
-
2018
- 2018-09-27 CN CN201811131554.XA patent/CN109198354A/en not_active Withdrawn
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1293963A (en) * | 2000-10-31 | 2001-05-09 | 华南理工大学 | Health-care microalga food and its preparing process |
| CN104687178A (en) * | 2015-03-13 | 2015-06-10 | 上海益力健营养品有限公司 | Solid beverage capable of being directly taken orally and preparation method thereof |
| CN105725005A (en) * | 2016-02-03 | 2016-07-06 | 山东禹王制药有限公司 | Protein type solid beverage with DHA fishy smell improved and preparing method thereof |
| CN106616184A (en) * | 2016-12-27 | 2017-05-10 | 哈药集团技术中心 | Mulberry DHA solid beverage, and preparation method thereof |
| CN108541859A (en) * | 2018-02-12 | 2018-09-18 | 广州富诺健康科技股份有限公司 | A kind of DHA algal oil solid beverage |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104432059B (en) | A kind of anti-acid microalgae DHA grease microscapsule powder | |
| CN103891924B (en) | A kind of ready-mixed oil containing corn oil and preparation method thereof | |
| CN100562254C (en) | A kind of plant blend oil | |
| CN105613789B (en) | High-fat high-dietary-fiber composite animal and plant powdered oil and fat, and preparation method and application thereof | |
| CN105053256A (en) | Flavored nutrition balanced blend oil | |
| CN107897466A (en) | A kind of antarctic krill oil interlayer type gel candy and preparation method thereof | |
| CN104719510A (en) | Pregnant woman and infant nutritional tea oil containing DHA and AA | |
| CN108402188A (en) | A kind of edible oil and preparation method for strengthening supplement DHA and alpha-linolenic acid | |
| CN102669306A (en) | Vitamin-E-enriched tea oil and preparation method thereof | |
| CN102488025B (en) | Tea-leaf healthcare blended oil and preparation method for same | |
| CN103300165A (en) | Healthcare edible blend oil with silybum marianum | |
| CN110353056A (en) | A kind of edible vegetable blend oil | |
| CN110179118A (en) | A kind of sunflower seeds nutrient blend oil microcapsules and preparation method thereof suitable for infant | |
| CN105961633A (en) | Peony seed oil blended oil and manufacturing method thereof | |
| CN106106850A (en) | A kind of Fructus Canarii albi sunflower mixed oil and preparation method thereof | |
| CN101044875A (en) | Health-care edible oil rich in perilla oil | |
| CN109198354A (en) | Intelligence development cerebrum tonifying DHA solid beverage and preparation method thereof | |
| CN110200085A (en) | A kind of sunflower seeds nutrient blend oil and preparation method thereof suitable for pregnant woman | |
| CN109527579A (en) | A kind of application of surprise Asia seed oil product and preparation method thereof and the sub- seed oil product of the surprise | |
| CN106900888A (en) | Fat or oil composition and its application containing odd-carbon fatty acid structured lipid | |
| CN106260120B (en) | A kind of selenium-rich edible blend oil and preparation method thereof | |
| CN105580926A (en) | Formula of selenium-containing beverage | |
| CN1298647A (en) | Health-care oil for regulating blood fat | |
| CN107114491A (en) | The elderly's tea oil and its production method | |
| Lee | Essent ial Fat ty Acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190115 |